Dosage form
Tablets №20.

Active ingredient
1 tablet contains cinnarizine, in terms of 100% of the substance - 75 mg.

Indications

Symptomatic treatment: labyrinthine disorders including vertigo, tinnitus, nystagmus, nausea and vomiting; cerebrovascular disorders, including dizziness, tinnitus (tintos), headache of vascular origin, irritability, impairment of memory and ability to concentrate; peripheral vascular disorders, including Raynaud's disease, acrocyanosis, intermittent claudication, trophic disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, a sensation of cold in the extremities.